European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending modestly lower late Tuesday morning, declining 0.16% to 1,445.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and pharmaceutical company Ascendis Pharma (ASND), which rose 6.8% and 5.7% respectively. They were followed by internet advertising firm Criteo (CRTO) and biotech firm BioNTech (BNTX), which increased 2.3% and 0.5% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and medical device maker EDAP TMS (EDAP), which fell 6.7% and 3.3% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which lost 2.8% and 1.5% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which were up 2% and 3.6% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and insurance company Prudential (PUK), which increased 3.4% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA), which tumbled 31.4%, followed by tobacco company British American Tobacco (BTI), which was down 2.7%. Pharmaceutical company GSK (GSK) and medical device maker Smith & Nephew (SNN) dropped 1.7% and 1.2% respectively.